MedTrace Logo

Mobile App-treatment of Mixed and Urgency Urinary Incontinence in Women

NCT03097549 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 142

Last updated 2025-02-19

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether a comprehensive treatment programme for self-management of mixed and urgency urinary incontinence via a mobile app is effective.

Conditions

Interventions

DEVICE

Tät®II Information app

Information about pelvic floor muscle training and bladder training for urgency and mixed urinary incontinence. Information about psychological factors and life style factors that might interfere with incontinence.

DEVICE

Tät®II Treatment app

Information about pelvic floor muscle training and bladder training for urgency and mixed urinary incontinence. Information about psychological factors and life style factors that might interfere with incontinence .Exercises for the pelvic floor muscles, for bladder training, and for behaviours of avoidance due to fear of leakage, a statistic function and possibility to set reminders. Individual advices regarding life style factors and training based on findings from the bladder diary and answers in the questionnaires.

Sponsors & Collaborators

  • Swedish Council for Working Life and Social Research

    collaborator OTHER

  • Jämtland County Council, Sweden

    collaborator OTHER_GOV

  • Norrlandstingens Regionförbund

    collaborator OTHER

  • Västerbotten County Council, Sweden

    collaborator OTHER_GOV

  • Umeå University

    lead OTHER

Principal Investigators

  • Eva C Samuelsson, MD, PhD · Department of public health and clinical medicine, Umeå university, Umeå, Sweden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-03
Primary Completion
2018-07-27
Completion
2018-09-19

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03097549 on ClinicalTrials.gov